SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML
Publication
, Conference
Fathi, AT; Erba, HP; Lancet, JE; Stein, EM; Walter, RB; DeAngelo, DJ; Faderl, S; Jillella, AP; Ravandi, F; Advani, AS; Bixby, D; O'Meara, MM ...
Published in: BLOOD
December 3, 2015
Duke Scholars
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 3, 2015
Volume
126
Issue
23
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
57th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Fathi, A. T., Erba, H. P., Lancet, J. E., Stein, E. M., Walter, R. B., DeAngelo, D. J., … Stein, A. S. (2015). SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML. In BLOOD (Vol. 126). Orlando, FL: AMER SOC HEMATOLOGY.
Fathi, Amir T., Harry P. Erba, Jeffrey E. Lancet, Eytan M. Stein, Roland B. Walter, Daniel J. DeAngelo, Stefan Faderl, et al. “SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML.” In BLOOD, Vol. 126. AMER SOC HEMATOLOGY, 2015.
Fathi AT, Erba HP, Lancet JE, Stein EM, Walter RB, DeAngelo DJ, et al. SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML. In: BLOOD. AMER SOC HEMATOLOGY; 2015.
Fathi, Amir T., et al. “SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML.” BLOOD, vol. 126, no. 23, AMER SOC HEMATOLOGY, 2015.
Fathi AT, Erba HP, Lancet JE, Stein EM, Walter RB, DeAngelo DJ, Faderl S, Jillella AP, Ravandi F, Advani AS, Bixby D, Kovacsovics TJ, O’Meara MM, Kennedy DA, Stein AS. SGN-CD33A Plus Hypomethylating Agents: A Novel, Well-Tolerated Regimen with High Remission Rate in Frontline Unfit AML. BLOOD. AMER SOC HEMATOLOGY; 2015.
Published In
BLOOD
EISSN
1528-0020
ISSN
0006-4971
Publication Date
December 3, 2015
Volume
126
Issue
23
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
57th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology